We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Fine Needle Biopsy Requires Trained Doctor

By HospiMedica staff writers
Posted on 12 Sep 2001
A study has found that doctors who had no formal training in performing a fine needle aspiration biopsy (FNAB) missed 25% of breast cancers at three U.S. More...
hospitals, while formally trained doctors there missed only 2% of cancers. The study, conducted by researchers from the University of California, San Francisco (UCSF, USA) was published in the August 25, 2001, issue of Cancer Cytopathology.

To determine that a cancer was missed, the researchers closely followed the medical histories of 927 women for a minimum of two years. They found that less-well-trained doctors were more likely to send samples to the lab that contained the wrong cells because of their poor sampling technique. The formally trained doctors had completed fellowship training in cytopathology or the equivalent and had performed at least 150 FNABs under supervision. The researchers note that FNAB is fast, inexpensive, and less likely to cause side effects like bleeding than more invasive methods but requires sampling accuracy.

The difference between the trained and untrained doctors was entirely due to errors in sampling the lesion rather than in interpreting the specimen, said the researchers. "The only factor that made a difference in the rate of accurate diagnosis was the training of the practitioner,” said Britt-Marie Ljung, M.D., lead author of the study.





Related Links:
Univ. of Calif.

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
Open Stapler
PROXIMATE Linear Cutter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.